Premature ejaculation, Opioid addicted. The inability to control ejaculation sufficiently for both partners to enjoy sexual interaction, Mental and behavioural disorders due to use of opioids.
Conditions
Interventions
Intervention 1: Intervention 1: Lavandula and Boswelia extracts combination, 500 mg capsules, Two times per day, Oral administrated, For two month. Intervention 2: Intervention2: Filling substances as
Treatment - Drugs
Placebo
Intervention 1: Lavandula and Boswelia extracts combination, 500 mg capsules, Two times per day, Oral administrated, For two month
Intervention2: Filling substances as a placebo, 500 mg capsules, Oral administered, Two times per day, For two month
Intervention3: Control group, They do not receive any treatment for premature ejaculation.
Sponsors
Vice Chancellor for Research and Technology, Shahid Beheshti University of Medical Sciences
Eligibility
Sex/Gender
Male
Age
20 Years to 50 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria : 1) Men (candidate for withdraws of opioids ) with premature ejaculation to be approved by a specialist 2) At first stage of treatment by methadone for withdraws of opioids 3) Age between 20 -50 years old 4) At least from three months ago they did not receive any treatments for premature ejaculation . Exclusion criteria are : 1) Patients with liver or kidney disorders. 2) Alcohol addicted patients 3) Patient who dose not obey from treatment pattern
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Ejaculation. Timepoint: Day Zero (Before treatment), One month after treatment, Two month after treatment. Method of measurement: Inventory premature ejaculation (AIPE), Erection questionnaire (IIEF). | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactFarzad Asefifar
Vice Chancellor for Research and Technology, Shahid Beheshti University of Medical Sciences
Outcome results
None listed